Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

AmplifiDX Inc
Profile last edited on: 11/16/23      CAGE: 8RJZ6      UEI: XAAGYAVXZM43

Business Identifier: Molecular point-of-care platform for rapid detection of infectious diseases
Year Founded
2020
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

9a Monument Squre Unit 1
Charlestown, MA 02129
   (408) 802-3465
   info@amplifidx.com
   www.amplifidx.com
Location: Single
Congr. District: 07
County: Suffolk

Public Profile

AmplifiDx is structured around developiment of a molecular point-of-care (POC) platform for rapid detection of infectious diseases to include STIs and respiratory diseases such as COVID-19. The firm's system lis structured such as to deliver highly sensitive results - indicated such as to being potentially omparable to commercial labs - while also being low-cost and yielding rapdly available - with the company’s goal being to have those results in some 30 minutes

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$400,000
Phase II Dollars
$0
Total Awarded
$400,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $400,000
Project Title: Cancer Prevention and Diagnosis Technologies for Low-Resource Settings
0 1 NIH $286,775
Project Title: STI NG Plus, a Swab to Answer Molecular Panel Test for Point of Care Diagnosis and Treatment Recommendation

Key People / Management

  Shoulian Dong -- Co-founder, CSO

  Nancy Schoenbrunner -- Founder and CEO

Company News

There are no news available.